Speaker
Christopher Lewis Reading
BioVie, Inc, USA
Biography :
Ph.D. in Biochemistry (UC Berkeley), post-doctoral studies in cancer biology UC Irvine) Faculty (MD Anderson Cancer Center and the University of Texas, Graduate School of Biomedical Sciences in Houston for 13 years, Associate Professor of Medicine (Department of Developmental Therapeutics, joint appointment in the Department of Tumor Biology). V.P. Product and Process Development (Systemix / Novartis). EVP R&D (Harbor Therapeutics, 15 years on the bezisterim platform development). Over 35 years R&D experience, 130 peer-reviewed scientific publications, and numerous patents in the areas of monoclonal antibodies, cell separation technologies, stem cell transplantation, and sterol drug development.
